These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 7798194

  • 1. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors.
    Blaikie P, Immanuel D, Wu J, Li N, Yajnik V, Margolis B.
    J Biol Chem; 1994 Dec 23; 269(51):32031-4. PubMed ID: 7798194
    [Abstract] [Full Text] [Related]

  • 2. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P, Wiley S, Lai VK, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S, Pawson T.
    Curr Biol; 1995 Apr 01; 5(4):404-12. PubMed ID: 7542991
    [Abstract] [Full Text] [Related]

  • 3. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T, Ishihara H, Sawa T, Ishiki M, Morioka H, Imamura T, Usui I, Takata Y, Kobayashi M.
    J Biol Chem; 1996 Aug 16; 271(33):20082-7. PubMed ID: 8702728
    [Abstract] [Full Text] [Related]

  • 4. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
    Dikic I, Batzer AG, Blaikie P, Obermeier A, Ullrich A, Schlessinger J, Margolis B.
    J Biol Chem; 1995 Jun 23; 270(25):15125-9. PubMed ID: 7541035
    [Abstract] [Full Text] [Related]

  • 5. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
    Liu SK, McGlade CJ.
    Oncogene; 1998 Dec 17; 17(24):3073-82. PubMed ID: 9872323
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
    Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG.
    Oncogene; 1994 Oct 17; 9(10):2827-36. PubMed ID: 8084588
    [Abstract] [Full Text] [Related]

  • 12. Binding of Shc to the NPXY motif is mediated by its N-terminal domain.
    Prigent SA, Pillay TS, Ravichandran KS, Gullick WJ.
    J Biol Chem; 1995 Sep 22; 270(38):22097-100. PubMed ID: 7673183
    [Abstract] [Full Text] [Related]

  • 13. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP, Songyang Z, Cantley L, Der CJ, Pawson T.
    Proc Natl Acad Sci U S A; 1996 Apr 02; 93(7):2729-34. PubMed ID: 8610109
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Src homologous and collagen (Shc) protein binds to F-actin and translocates to the cytoskeleton upon nerve growth factor stimulation in PC12 cells.
    Thomas D, Patterson SD, Bradshaw RA.
    J Biol Chem; 1995 Dec 01; 270(48):28924-31. PubMed ID: 7499422
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.